Reports for MYLAN PHARMACEUTICALS ULC
Formerly known as UPJOHN CANADA ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Shortage reports
Actual shortage:
31 (4%)
Anticipated shortage:
1 (0%)
Avoided shortage:
89 (11%)
Resolved:
658 (84%)
779
Discontinuation Reports
To be discontinued:
0 (0%)
Discontinued:
235 (100%)
Reversed:
0 (0%)
235
101 (10%)
5 (16%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2024-05-21 | 2024-06-25 | 228363 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-10-11 | 2023-11-28 | 206781 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2025-09-09 | 2025-09-09 | 266824 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2025-12-15 | 2026-01-13 | 274395 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-06-16 | 2018-10-10 | 13187 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-04-12 | 2023-05-01 | 189345 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-01-15 | 2020-07-10 | 72306 |
| CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-12-21 | 2024-01-10 | 213971 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-07-09 | 2024-09-24 | 232550 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-10-29 | 2020-03-18 | 97440 |
| CLARUS | 10MG | CAPSULE | Resolved | 2017-03-10 | 2017-03-22 | 143 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-07-09 | 2019-07-17 | 88979 |
| CLARUS | 40MG | CAPSULE | Resolved | 2022-01-13 | 2022-04-13 | 152648 |
| CLARUS | 10MG | CAPSULE | Resolved | 2021-06-30 | 2021-12-21 | 141675 |
| CLARUS | 10MG | CAPSULE | Resolved | 2022-06-18 | 2022-09-01 | 163042 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-12-03 | 2025-01-07 | 244622 |
| CLARUS | 10MG | CAPSULE | Resolved | 2019-04-03 | 2019-05-08 | 80416 |
| CLARUS | 40MG | CAPSULE | Resolved | 2017-03-10 | 2017-03-22 | 148 |
| CLARUS | 10MG | CAPSULE | Resolved | 2021-04-13 | 2021-06-24 | 137415 |
| CLARUS | 10MG | CAPSULE | Resolved | 2024-10-04 | 2024-11-18 | 239457 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-RISEDRONATE | 35MG | TABLET | Discontinued | 2017-07-18 | 2017-11-02 | 16151 |
| MYLAN-RISPERIDONE | 1.0MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16160 |
| MYLAN-RISPERIDONE | 0.50MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16157 |
| MYLAN-RISPERIDONE | 0.25MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16154 |
| MYLAN-RISPERIDONE | 2.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16163 |
| MYLAN-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16166 |
| MYLAN-RISPERIDONE | 4.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16169 |
| MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
| MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
| MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
| MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
| MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
| MYLAN-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-04-04 | 2018-07-04 | 44907 |
| MYLAN-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2017-11-23 | 2018-05-02 | 30350 |
| MYLAN-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2017-11-23 | 2018-07-04 | 30385 |
| MYLAN-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2017-11-23 | 2018-04-03 | 30342 |
| MYLAN-SELEGILINE | 5MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16054 |
| MYLAN-SERTRALINE | 100MG | CAPSULE | Discontinued | 2017-11-23 | 2018-02-15 | 30356 |
| MYLAN-SERTRALINE | 50MG | CAPSULE | Discontinued | 2017-08-24 | 2018-03-02 | 20295 |
| MYLAN-SERTRALINE | 25MG | CAPSULE | Discontinued | 2017-11-23 | 2018-02-15 | 30397 |